Financing Pharmaceutical Expenditures in OECD Countries: Modern State and Tendencies
This article discusses the problems of financing of medicines supply in OECD countries. Detailed analysis of the statistical data is provided in the three basic positions, viz the total pharmaceutical expenditures, the level of consumption of medicines and the extent of the use of generics. This allows to compare the situation in health care systems in these countries in terms of developing policy, aimed at securing population assess to medicine. The author concludes that is necessary to continue the analysis of the characteristics and the institutional structure of the pharmaceutical market and its regulation by the state for the optimization of the health care cost.